Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists. Επικοινωνία Submitted by Στέργιος Πολύζος on Δευ, 11/18/2019 - 11:13
